Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-15, with 15 holding rows worth $88,642,000.

Accession
0000919574-16-014769
Filed
2016-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2016

A holdings report, 15 entries on the cover page, a total value of $88,642,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $88,642,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELATOR PHARMACEUTICALS INC15089R102Cmn2,232,272$67,370,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
AGILE THERAPEUTICS INC00847L100COM1,580,491$12,028,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
Synta Pharmaceuticals Corp.87162T206COM21,770,662$5,665,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
Berkshire Hathaway Inc084670702COM8,945$1,295,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CSW INDUSTRIALS INC126402106COM11,253$367,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
STELLUS CAP INVT CORP858568108COM29,728$304,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CM FIN INC COM12574Q103COM33,247$295,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
PARATEK PHARMACEUTICALS INC699374302Equity18,909$263,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
DOVER CORP COM260003108Stock3,224$223,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CIDARA THERAPEUTICS INC COM NEW171757107Stock18,807$194,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MEDLEY CAP CORP58503F106COM24,913$167,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
AMERICAN CAP SR FLOATING LTD02504D108COM15,255$157,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
GARRISON CAP INC366554103COM15,104$152,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD35,977$143,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
Synta Pharmaceuticals Corp.87162T206COM72,000$19,000thousands by filing datecallThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-16-014769this filing2016-08-15acceptance time not in the bulk data set